Desktop Site
|
19 Apr 24 | 16:00
|
Close
Equity
SME
Eq Drv
Currency
Commodity
Corporates
Get Quote
*
Notices
|
S&P
BSE SENSEX
73,088.33
+599.34
+0.83 %
Corporate Announcement
Security Code
532296
Company
Glenmark Pharmaceuticals Ltd
Exchange Received Time
08/12/2017 08:55:00
Exchange Disseminated Time
08/12/2017 08:55:07
Time Taken
00:00:07
Press Release / Media Release |
12/08/17 08:55
Dear Sirs,
Sub: Glenmark Pharmaceuticals Announces Dosing of First Patient with Investigational Immuno-Oncology Agent GBR 1342
With reference to the subject mentioned above, kindly find attached media release which is self-explanatory.
Request you to kindly take the same on record.
Thanking you,
Yours faithfully,
For Glenmark Pharmaceuticals Limited
Harish Kuber
Company Secretary & Compliance Officer
Attachment
<< Back
Recently Viewed